After Pentagon Inks Deal With AI Firms, Buy These Under $20 Stocks

Photo of Alex Sirois
By Alex Sirois Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
After Pentagon Inks Deal With AI Firms, Buy These Under $20 Stocks

© Fox Photos / Hulton Archive via Getty Images

The Pentagon’s accelerating push to embed artificial intelligence across defense and national security operations has put a spotlight on a small group of pure-play federal AI vendors. With the U.S. Government’s AI Acceleration Strategy now driving real bookings, two NYSE-listed names trading well under $20 have moved from speculative bets to credible defense AI plays. Both are unprofitable, both are volatile, and both sit squarely in the path of a generational federal spend on disruptive defense tech.

With that in mind, here are two stocks trading under $20 that look positioned to benefit as Pentagon AI dollars flow.

C3.ai (NYSE: AI)

C3.ai (NYSE:AI | AI Price Prediction) is an enterprise AI software company supplying agentic and generative AI applications to large commercial customers and a growing roster of federal agencies, including the U.S. Air Force, Department of Energy, and NATO.

Shares began May up 8.15% over the past month but down 58.04% over the past year. For a retail investor, that single-digit handle reflects a deeply discounted business in transition rather than a quiet compounder.

The fundamentals are ugly in the near term. Q3 FY2026 revenue came in at $53.26 million, down 46.1% YoY, missing expectations by 29.59%, with non-GAAP EPS of -$0.40 and gross margin collapsing to 17%. Market cap sits near $1.30 billion, and the P/E is negative at -4.50.

The bull case rests on the federal mix. Federal, defense, and aerospace bookings rose 134% YoY in Q3 and now represent 55% of total bookings, with 90% of revenue recurring through subscriptions. A 26% workforce reduction is expected to deliver roughly $135 million in annual non-GAAP operating expense savings. CEO Stephen Ehikian told investors the company is now “a more agile, more disciplined, and more accountable organization” focused on a return to growth.

The risk that cuts against the thesis is real: cash burn is accelerating, with Q3 free cash flow of -$56.20 million, and securities class actions are pending over disclosure of the prior CEO’s health. For investors who can stomach that, AI stock offers leveraged exposure to federal AI spending at a beaten-down valuation.

BigBear.ai (NYSE: BBAI)

BigBear.ai (NYSE:BBAI) builds AI-powered decision intelligence software for national security, defense, border security, and travel and trade customers, with the U.S. government as its anchor client.

The stock has trended up 21.05% over the past month and 23.95% over the past year. At that price, it is accessible to small accounts but carries a beta of 3.236, so volatility is part of the package.

Q4 2025 revenue was $27.3 million, down 38% YoY, with EPS of -$0.01 and gross margin of 20.3%. Market cap is roughly $1.98 billion, and the analyst target price stands at $5.33.

The bull case is the balance sheet plus the pipeline. BigBear.ai raised $693 million through ATM facilities and warrants, converted $125 million in convertible notes to equity, cut debt by more than 90%, and finished 2025 with $462 million in total cash and investments. The $250 million Ask Sage acquisition added a generative AI platform serving 100,000+ users across 16,000 government teams, and backlog now exceeds $400 million. Management guided 2026 revenue to $135 million to $165 million. CEO Kevin McAleenan said the One Big Beautiful Bill brings “over $170 billion in supplemental funding to the Department of Homeland Security, and $150 billion to the Department of Defense for disruptive defense technology.”

The key risk is concentration. A material weakness in internal control over financial reporting, DOGE-related contract pressure, and reliance on federal customers all loom. Even so, BBAI looks like a direct play on the Pentagon AI thesis.

The Bottom Line

A low share price by itself is never a reason to buy or avoid a stock. Both AI and BBAI carry real execution, legal, and contract concentration risks that a $20 ceiling does not erase. Use this list as a starting point for research on federal AI exposure, then dig into the filings, guidance, and risk factors before committing capital.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

MOS Vol: 14,295,760
STX Vol: 3,198,282
ALB Vol: 3,265,097
INTC Vol: 151,379,140
WDC Vol: 6,291,434

Top Losing Stocks

CTRA Vol: 73,319,495
ADBE Vol: 25,063,608
LEN Vol: 6,260,516
TKO Vol: 1,889,802
SMCI Vol: 85,032,138